104 related articles for article (PubMed ID: 11322203)
1. Inactivation of SSI-1, a JAK/STAT inhibitor, in human hepatocellular carcinomas, as revealed by two-dimensional electrophoresis.
Nagai H; Kim YS; Lee KT; Chu MY; Konishi N; Fujimoto J; Baba M; Matsubara K; Emi M
J Hepatol; 2001 Mar; 34(3):416-21. PubMed ID: 11322203
[TBL] [Abstract][Full Text] [Related]
2. Combined hypermethylation and chromosome loss associated with inactivation of SSI-1/SOCS-1/JAB gene in human hepatocellular carcinomas.
Nagai H; Kim YS; Konishi N; Baba M; Kubota T; Yoshimura A; Emi M
Cancer Lett; 2002 Dec; 186(1):59-65. PubMed ID: 12183076
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation associated with inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human hepatoblastomas.
Nagai H; Naka T; Terada Y; Komazaki T; Yabe A; Jin E; Kawanami O; Kishimoto T; Konishi N; Nakamura M; Kobayashi Y; Emi M
J Hum Genet; 2003; 48(2):65-9. PubMed ID: 12601549
[TBL] [Abstract][Full Text] [Related]
4. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity.
Yoshikawa H; Matsubara K; Qian GS; Jackson P; Groopman JD; Manning JE; Harris CC; Herman JG
Nat Genet; 2001 May; 28(1):29-35. PubMed ID: 11326271
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation-associated inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human pancreatic cancers.
Komazaki T; Nagai H; Emi M; Terada Y; Yabe A; Jin E; Kawanami O; Konishi N; Moriyama Y; Naka T; Kishimoto T
Jpn J Clin Oncol; 2004 Apr; 34(4):191-4. PubMed ID: 15121754
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.
Calvisi DF; Ladu S; Gorden A; Farina M; Conner EA; Lee JS; Factor VM; Thorgeirsson SS
Gastroenterology; 2006 Apr; 130(4):1117-28. PubMed ID: 16618406
[TBL] [Abstract][Full Text] [Related]
7. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma.
Niwa Y; Kanda H; Shikauchi Y; Saiura A; Matsubara K; Kitagawa T; Yamamoto J; Kubo T; Yoshikawa H
Oncogene; 2005 Sep; 24(42):6406-17. PubMed ID: 16007195
[TBL] [Abstract][Full Text] [Related]
8. Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis.
Okochi O; Hibi K; Sakai M; Inoue S; Takeda S; Kaneko T; Nakao A
Clin Cancer Res; 2003 Nov; 9(14):5295-8. PubMed ID: 14614012
[TBL] [Abstract][Full Text] [Related]
9. Isolation of NotI clusters hypomethylated in HBV-integrated hepatocellular carcinomas by two-dimensional electrophoresis.
Nagai H; Baba M; Konishi N; Kim YS; Nogami M; Okumura K; Emi M; Matsubara K
DNA Res; 1999 Aug; 6(4):219-25. PubMed ID: 10492168
[TBL] [Abstract][Full Text] [Related]
10. Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling.
Narazaki M; Fujimoto M; Matsumoto T; Morita Y; Saito H; Kajita T; Yoshizaki K; Naka T; Kishimoto T
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13130-4. PubMed ID: 9789053
[TBL] [Abstract][Full Text] [Related]
11. Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 is involved in gp130 resistance in cardiovascular system in rat treated with cardiotrophin-1 in vivo.
Hamanaka I; Saito Y; Yasukawa H; Kishimoto I; Kuwahara K; Miyamoto Y; Harada M; Ogawa E; Kajiyama N; Takahashi N; Izumi T; Kawakami R; Masuda I; Yoshimura A; Nakao K
Circ Res; 2001 Apr; 88(7):727-32. PubMed ID: 11304496
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays.
Tannapfel A; Anhalt K; Häusermann P; Sommerer F; Benicke M; Uhlmann D; Witzigmann H; Hauss J; Wittekind C
J Pathol; 2003 Oct; 201(2):238-49. PubMed ID: 14517841
[TBL] [Abstract][Full Text] [Related]
13. Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3.
Minamoto S; Ikegame K; Ueno K; Narazaki M; Naka T; Yamamoto H; Matsumoto T; Saito H; Hosoe S; Kishimoto T
Biochem Biophys Res Commun; 1997 Aug; 237(1):79-83. PubMed ID: 9266833
[TBL] [Abstract][Full Text] [Related]
14. Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma.
Miyoshi H; Fujie H; Moriya K; Shintani Y; Tsutsumi T; Makuuchi M; Kimura S; Koike K
J Gastroenterol; 2004 Jun; 39(6):563-9. PubMed ID: 15235874
[TBL] [Abstract][Full Text] [Related]
15. Structure and function of a new STAT-induced STAT inhibitor.
Naka T; Narazaki M; Hirata M; Matsumoto T; Minamoto S; Aono A; Nishimoto N; Kajita T; Taga T; Yoshizaki K; Akira S; Kishimoto T
Nature; 1997 Jun; 387(6636):924-9. PubMed ID: 9202127
[TBL] [Abstract][Full Text] [Related]
16. Suppressors of cytokine signalling (SOCS): putative modulators of cytokine bioactivity in health and disease.
Diamond P; Doran P; Brady HR; McGinty A
J Nephrol; 2000; 13(1):9-14. PubMed ID: 10720209
[TBL] [Abstract][Full Text] [Related]
17. SOCS proteins: negative regulators of cytokine signaling.
Krebs DL; Hilton DJ
Stem Cells; 2001; 19(5):378-87. PubMed ID: 11553846
[TBL] [Abstract][Full Text] [Related]
18. IFN regulatory factor-1-mediated transcriptional activation of mouse STAT-induced STAT inhibitor-1 gene promoter by IFN-gamma.
Saito H; Morita Y; Fujimoto M; Narazaki M; Naka T; Kishimoto T
J Immunol; 2000 Jun; 164(11):5833-43. PubMed ID: 10820262
[TBL] [Abstract][Full Text] [Related]
19. Genomic aberrations in early stage human hepatocellular carcinomas.
Nagai H; Ponglikitmongkol M; Fujimoto J; Yamamoto H; Kim YS; Konishi N; Matsubara K
Cancer; 1998 Feb; 82(3):454-61. PubMed ID: 9452261
[TBL] [Abstract][Full Text] [Related]
20. Subcellular mislocalization of mutant hepatitis B X proteins contributes to modulation of STAT/SOCS signaling in hepatocellular carcinoma.
Bock CT; Toan NL; Koeberlein B; Song le H; Chin R; Zentgraf H; Kandolf R; Torresi J
Intervirology; 2008; 51(6):432-43. PubMed ID: 19321929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
